India to crack the whip against firms flouting drug safety reporting norms
This article was originally published in Scrip
Executive Summary
Call it the effect of the damning Parliamentary committee report or maybe just part of concerted efforts to improve the country's regulatory system, but the Drugs Controller General of India (DCGI) has decided to crack the whip against firms that donot take their safety reporting obligations seriously.